Download PDF
Thromb Haemost 1989; 62(02): 817
DOI: 10.1055/s-0038-1646913
Letters to the Editor
Schattauer GmbH Stuttgart

Antithrombin III and Hepatocellular Carcinoma

J J Lefrére
*   Institut National de Transfusion Sanguine 6, rue Alexandre-Cabanel 75015 Paris, France
,
J Conard
**   Laboratoire Central d’hématologie, Hâpital de l’Hâtel-Dieu Paris, France
,
J Lerable
*   Institut National de Transfusion Sanguine 6, rue Alexandre-Cabanel 75015 Paris, France
,
M Samama
**   Laboratoire Central d’hématologie, Hâpital de l’Hâtel-Dieu Paris, France
› Author Affiliations
Further Information

Publication History

Received 13 March 1989

Accepted after revision 04 April 1989

Publication Date:
30 June 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Leone G, DeStefano V, Garufi C, Ferrelli R, Cassano A, Grieco A. Antithrombin III in patients with hepatocellular carcinoma. Thromb Haemostas 1987; 58 (04) 1093
    PubMedGoogle Scholar
  • 2 Lefrère JJ, Gozin D, Bettan L. Proaccelerin and prothrombin assays for detection of hepatocellular carcinoma. Hepatology 1987; 7 (02) 414
    PubMedGoogle Scholar
  • 3 Liebman HA, Furie BC, Tong MJ. et al Des-gammacarboxy (as normal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310: 1427-1431
    CrossrefPubMedGoogle Scholar